CEO Q&A with Dr Michael Edelman at Nanoco Group PLC (LON:NANO)

Nanoco Group PLC (LON:NANO) Chief Executive Officer Dr Michael Edelman caught up with DirectorsTalk for an exclusive interview to discuss the progress with their new US partner, their display technology coming to market, cash position and other target markets.

 

Q1: Michael, can you talk about the progress that’s been made with your new US partner?

A1: We and our large US partner are really pleased with the progress to date, the programme is on track, the new Runcorn production facility will be completed and fully commissioned by this calendar year-end. We will then move into a period of stress-testing the facility before volume production can enter second half of calendar 2019.

 

Q2: Display finally looks like we should see products containing Nanoco’s technology in the market this calendar year, can you give some more detail around that?

A2: Display has taken longer to materialise, but we are finally seeing the first products heading for the market. The first display products are gaming monitors being manufactured by our Taiwanese partners and we look forward to seeing these products on the shelves for the coming holiday season.

 

Q3: Now, it’s very encouraging to see that your cash position has improved since your half year, are you comfortable with the funding of the business going forward?

A3: Yes, cash, as you note, has increased by £2 million since we last reported 6 months ago, we’ve worked really hard to keep all costs within the business down and we believe Nanoco Group remains in a strong cash position.

 

Q4: Can you add or update us on the progress in Nanoco Group’s other target markets?

A4: Lighting has made good progress, we’re focussed on niche lighting applications namely horticultural lighting and more specifically, vertical farming. Additionally, our US customer CareWear has launched its medical device lighting products into the US market focussed on professional sports teams and our life sciences business has made excellent pre-clinical progress in the diagnosis and imaging of pancreatic cancer.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Nanoco Group PLC

More articles like this

Nanoco Group PLC

Nanoco to return up to £30m to shareholders

Nanoco is to use £33m from the proceeds from its successful litigation against Samsung to buy up its own shares. Nanoco’s board is to conduct a Tender Offer to return up to £30m to shareholders and

Nanoco Group PLC

The fascinating world of Quantum Dots

Quantum dots are nanoscale semiconductor particles that have unique optical and electronic properties due to their quantum mechanical characteristics. The size and shape of these quantum dots can be finely tuned to control their color and optical properties, making

Nanoco Group PLC

Understanding Quantum Dots: Excitement in the patent world

In the world of science, there exists a realm so tiny, yet so powerful, known as “Quantum dots.” It challenges our conventional understanding of materials and light. These minuscule structures exhibit properties distinct from those observed

Nanoco Group PLC

Revolutionising solar energy storage with Quantum Dots

Quantum dots have the potential to revolutionize solar energy storage systems and green hydrogen production. Their unique properties enable them to absorb a wider range of light wavelengths, increasing solar cell efficiency and paving the way

Nanoco Group PLC

Nanoco receives final litigation proceeds from Samsung

Nanoco Group plc (LON:NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials emanating from its technology platform, has announced that it has received the second tranche of litigation proceeds from Samsung